The National Sarcoma Survey 2015

Slides:



Advertisements
Similar presentations
Knowledge Synthesis: Six Steps to Information and Evidence in a palliative care website Tieman JJ, Rawlings D JBI Conference August 2012.
Advertisements

MDS National Survey Assessing the needs for support Monika Janosik MDS UK Project Worker The Lancaster Hotel London 3 rd October 2014.
Cancer Clinical Trials: The Way We Make Progress Against Cancer.
Patient Experience: Why does it matter?
National Cancer Survivorship Initiative Central Hall, Westminster Monday 21 September 2009 Assessment and Care Planning.
TargetWhat is happening How are we doing on this What is happening in health? The red, amber or green face shows how well we are doing. Most of our targets.
INAUGURAL NI AHP CONFERENCE 2013: Wednesday, 23 October Wednesday, 23 October, Lagan Valley Island, Lisburn “AHP’s – Transforming Your Care”
Our five year plan to improve local health and care services.
Adult Autism Service ADULT AUTISM TEAM PRESENTATION JULY
2015/16 National Cancer Patient Experience Survey
Transforming Aftercare Pathways: Your Voice
Our five year plan to improve local health and care services
Implementing the ‘recovery package’
Do you want to be involved?
Bladder Cancer (C67): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.5% 66.5% 63.6% patients treated for cancer.
Westgate Practice During our flu clinic in November we conducted a survey asking patients how they had heard about the clinic. Out of the patients that.
Sarcoma: Cancer Waiting Times, UK countries England Wales
Module 2: Orientation to the Role of an Advisory Coalition
‘ACHIEVING WORLD CLASS CANCER OUTCOMES’
Bone Cancer (C40-C41): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.4% 50.0% 51.7% patients treated for.
Recognition and Referral of Suspected cancer NICE NG12 – 2Week Wait
Dr James Carlton, Medical Adviser
Cervical Cancer (C53): 2014 Cancer Patient Experience Survey, by Sex, England Female Percentage of 62.9% patients treated for cancer who visited their.
Local networking sessions
Achieving World-Class Cancer Outcomes A Strategy for England
In Situ Breast Carcinoma: 2014
Breast Cancer (C50): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 87.5% 83.3% 87.4% patients treated for cancer.
Achieving World-Class Cancer Outcomes A Strategy for England
Hodgkin Lymphoma (C81): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 34.2% 43.8% 39.2% patients treated for.
Achieving World-Class Cancer Outcomes A Strategy for England
Achieving World-Class Cancer Outcomes A Strategy for England
Healthy Together Clinic
Nurse Role & NET Education An Electronic Survey Across 26 Countries
Laryngeal Cancer (C32): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 47.1% 51.0% 50.3% patients treated for.
Brain, Other CNS and Intracranial Tumours, Malignant (C70-C72, C75
Stomach Cancer (C16): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 39.0% 51.7% 48.0% patients treated for cancer.
Achieving World-Class Cancer Outcomes A Strategy for England
Non-Hodgkin Lymphoma (C82-C85): 2014
National Cancer Patient Experience (NCPES) Results 2017
A Partnership Approach
National Cancer Patient Experience (NCPES) Results 2017
Right place, right time Working to improve hospital discharge and prevent admissions in South Tyneside South Tyneside Patient Reference Group August 2016.
National Cancer Patient Experience Survey
2015/16 National Cancer Patient Experience Survey
Achieving World-Class Cancer Outcomes A Strategy for England
Liver Cancer (C22): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 42.2% 57.1% 52.8% patients treated for cancer.
Ovarian Cancer (C56-C57.4): 2014 Cancer Patient Experience Survey, Females, England Female Percentage of 47.0% patients treated for cancer who visited.
Chronic Myeloid Leukaemia (C92.1): 2014
National Cancer Patient Experience Survey 2015
Eye Cancer (C69): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 86.4% 76.6% 80.9% patients treated for cancer.
2016 NCPES Inpatient and day case adult cancer patients, discharged from hospital 01/04/16 – 30/06/16 Sent postal questionnaires Oct’16 – March ’17 National.
Thanking Donors Personal Visual impact Donor impact Clear result
Kidney Cancer (C64-C66,C68): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.5% 62.2% 59.2% patients treated.
Nurse Role & NET Education An Electronic Survey Across 26 Countries
Cancer Survivorship: Transforming how we deliver cancer care
National Cancer Patient Experience (NCPES) Results 2017
Sian Middleton, Lead Nurse for Cancer, Gloucestershire Hospitals.
Lung Cancer (C33-C34): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 50.3% 51.4% 50.9% patients treated for.
Prostate Cancer (C61): 2014 Cancer Patient Experience Survey, Males, England Male Percentage of 51.9% patients treated for cancer who visited their GP.
Myeloma (C90): 2014 Cancer Patient Experience Survey, by Sex, England
Acute Myeloid Leukaemia (C92.0 C92.4 C92.5 C93.0 C94.0 C94.2): 2014
National Cancer Patient Experience (NCPES) Results 2017
Cancer Patient Experience Survey, by Sex, England Female Male Persons
Pancreatic Cancer (C25): 2014
Living Well With and Beyond Cancer University Hospitals Bristol
Gallbladder Cancer (C23): 2014
Living Well With and Beyond Cancer
Anal Cancer (C21): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 45.9% 60.8% 50.9% patients treated for cancer.
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Mental Health Navigator
Presentation transcript:

The National Sarcoma Survey 2015 Cancer 52 All members meeting Tuesday 5th July 2016 Clare Soares Lindsey Bennister

Contents General information Diagnosis Treatment Post-treatment Next steps

Sarcoma UK Quality Health Expert panel of Patients and Clinicians 650 respondents (64%) England – Previously completed Cancer Patient Experience Survey Scotland – Self selected

Transforming patient experience

Patient experiences of Diagnostic Pathways in Sarcoma What were the main symptoms that first made you think something was wrong? How long was it from the time you noticed these symptoms and first seeing a GP? If you went to see a GP about your symptoms, what did the GP do?

2. How long was it from the time you noticed these symptoms and first seeing a GP? 18% of all sarcoma patients presented 6 months or later. 24% of bone sarcoma patients presented 6 months or later (including 17% who waited more than a year). 16% of soft tissue sarcoma patients presented 6 months or later.

3. If you went to see a GP about your symptoms, what did the GP do? 34% were referred for tests/x-rays/scans 33% were referred to a specialist 5% were sent straight to hospital the same day There was no difference between bone & soft tissue sarcoma patients. = GP took action in 70% of cases

Patient experiences of Treatment for Sarcoma Were you treated by a Specialist Sarcoma Cancer team? Was there always a Clinical Nurse Specialist in chare of your care? How many hospitals did you have to attend for treatment?

4. Were you treated by a Specialist Sarcoma Cancer team? 3% Were not treated by a Specialist sarcoma cancer team 87% Treated by a Specialist sarcoma cancer team 10% Not sure if they were or not

1 in 10 did not have access to a CNS

6. How many hospitals did you have to attend for treatment 34% Attended one hospital 45% Attended two hospitals 21% Attended three or more hospitals Did you mind travelling the distance you had to travel? 90% - NO

Patient experiences of Treatment for Sarcoma Three important findings: Clinical trials Sides effects Written treatment plan

Overall only 22% of those asked went on to take part in a trail Clinical Trials 67% NOT asked if they wanted to take part in a clinical trail 32% were asked (28% asked to take part at the hospital where they were being treated, 4% asked to take part at another hospital) Overall only 22% of those asked went on to take part in a trail Younger people more likely to be asked to participate than older patients Scotland patients less likely to be asked compared to England

Written Treatment Plan 87% Were given enough information to help them make decisions about their care and treatment However about 4 in 10 patients were not given a written treatment plan “I would have liked clearer communication about my treatment plan, and once treatment has finished, clear information about follow up “

Patient experiences of Rehabilitation and Support At the end of treatment, were you referred to any of the following rehabilitation services? When treatment finished, what were you most worried about?

Did rehabilitation services help? 63% Bone 48% Soft tissue

Summary First survey of it’s kind conducted by Sarcoma UK Six areas for improving patient experience: Early suspicion of Sarcoma Streamlined routes into sarcoma specialist services Clear navigation within sarcoma specialist services Emotional support Access to specialist sarcoma rehabilitation services Information about Clinical trials

Sarcoma UK activities 2016 – Snapshot Sarcoma awareness week 4th July – 53% of the public have not heard of Sarcoma. Daily Mirror website of the week CE on London Live “What is Sarcoma” Social media campaign “Sarcoma and you” Online photo exhibition GP and clinicians: Golf ball campaign, BMJ module, Conference and journal abstracts and papers Patient support groups, Support line, Information booklets, Actively involved in health professional groups Fund research

Thank you clare.soares@sarcoma.org.uk